As of 2026-05-26, the EV/EBITDA ratio of Strides Pharma Science Ltd (STAR.NS) is 11.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STAR.NS's latest enterprise value is 126,517.27 mil INR. STAR.NS's TTM EBITDA according to its financial statements is 10,558.19 mil INR. Dividing these 2 quantities gives us the above STAR.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 16.3x | 15.0x |
| Forward P/E multiples | 10.7x - 14.2x | 12.9x |
| Fair Price | 834.19 - 1,682.64 | 1,290.99 |
| Upside | -29.8% - 41.6% | 8.7% |
| Date | EV/EBITDA |
| 2026-05-25 | 11.98 |
| 2026-05-22 | 11.60 |
| 2026-05-21 | 11.77 |
| 2026-05-20 | 11.61 |
| 2026-05-19 | 11.62 |
| 2026-05-18 | 11.26 |
| 2026-05-15 | 11.62 |
| 2026-05-14 | 11.66 |
| 2026-05-13 | 11.62 |
| 2026-05-12 | 11.74 |
| 2026-05-11 | 11.70 |
| 2026-05-08 | 11.82 |
| 2026-05-07 | 11.65 |
| 2026-05-06 | 11.17 |
| 2026-05-05 | 10.83 |
| 2026-05-04 | 10.67 |
| 2026-04-30 | 10.67 |
| 2026-04-29 | 10.80 |
| 2026-04-28 | 10.84 |
| 2026-04-27 | 11.15 |
| 2026-04-24 | 10.89 |
| 2026-04-23 | 11.00 |
| 2026-04-22 | 10.34 |
| 2026-04-21 | 10.29 |
| 2026-04-20 | 10.28 |
| 2026-04-17 | 10.36 |
| 2026-04-16 | 10.31 |
| 2026-04-15 | 10.38 |
| 2026-04-13 | 10.35 |
| 2026-04-10 | 10.34 |
| 2026-04-09 | 10.30 |
| 2026-04-08 | 9.98 |
| 2026-04-07 | 10.28 |
| 2026-04-06 | 10.14 |
| 2026-04-02 | 10.07 |
| 2026-04-01 | 9.94 |
| 2026-03-30 | 9.73 |
| 2026-03-27 | 9.77 |
| 2026-03-25 | 9.69 |
| 2026-03-24 | 9.56 |
| 2026-03-23 | 9.46 |
| 2026-03-20 | 9.50 |
| 2026-03-19 | 9.45 |
| 2026-03-18 | 9.49 |
| 2026-03-17 | 9.25 |
| 2026-03-16 | 9.35 |
| 2026-03-13 | 9.57 |
| 2026-03-12 | 9.56 |
| 2026-03-11 | 9.35 |
| 2026-03-10 | 9.23 |